Duane Rudisill

Duane Rudisill is an experienced professional in the field of chemical development, currently serving as the Director of Chemical Development at Bristol Myers Squibb since January 2024. Prior to this role, Rudisill held the position of Director of Chemical Development at Mirati Therapeutics from February 2021 to February 2024 and served as a Senior Scientist at Myovant Sciences, Inc. from February 2018 to February 2021. Additional experience includes being a Group Leader at Ash Stevens Inc from June 2011 to February 2018 and an Assistant Director at sanofi-aventis from January 2009 to May 2011. Educational credentials comprise a BA in chemistry from UC San Diego, a Ph.D. in organometallic chemistry from UC Irvine, and a post-doctoral fellowship in synthetic organic chemistry from Colorado State University.